Novartis48m
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
US FDA expands approval for Alnylam's drug to treat rare heart disease
U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, allowing the ...
Alnylam's Amvuttra Gets Approval for Expanded Indication From FDA
Alnylam Pharmaceuticals' amyloidosis drug Amvuttra received Food and Drug Administration approval for an expanded indication.
US FDA approves Alnylam's drug for rare heart condition
U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, allowing the ...
US FDA announces online database to track food contaminants
The U.S. Food and Drug Administration on Thursday launched an online searchable database listing contaminant levels in human ...
National Law Review12h
FDA Completes Pre-Market Consultation for Food Made With Cultured Pork Fat Cells
FDA announced that is has no questions regarding a human food product made from cultured pork fat cells, finding that the ...
Inquirer Business on MSN23h
DA expects FDA go-ahead for hog vaccines in April
The Department of Agriculture (DA) hopes to secure the approval of the Food and Drug Administration (FDA) by next month for ...